News - FORMA Therapeutics


Current filters:

FORMA Therapeutics

Popular Filters

FORMA meets milestones under Boehringer Ingelheim cancer accord

FORMA meets milestones under Boehringer Ingelheim cancer accord


US drug discovery company FORMA Therapeutics revealed that it has achieved several discovery milestones…

Boehringer IngelheimFORMA TherapeuticsLicensingOncologyPharmaceuticalResearch

Celgene partners with FORMA Thera on drugs targeting protein homeostasis


Privately-held FORMA Therapeutics has entered into a strategic collaboration agreement with US biotech…

BiotechnologyCelgeneFORMA TherapeuticsLicensingNeurologicalOncologyResearch

Another mega deal for FORMA Therapeutics


Hot on the heels of its up to $815 million oncology-related deal with Boehringer Ingelheim (The Pharma…

BiotechnologyFORMA TherapeuticsJanssen BiotechJohnson & JohnsonLicensingOncologyPharmaceuticalResearch

FORMA Thera in up to $815 million deal with Boehringer


Fast-growing US drug discovery firm FORMA Therapeutics has entered into an R&D collaboration with family-owned…

Boehringer IngelheimFORMA TherapeuticsOncologyPharmaceuticalResearch

Roche’s Genentech in preclinical cancer program deal with FORMA Therapeutics


Cambridge, Massachusetts, USA-based small-molecule therapeutics developer FORMA Therapeutics has entered…

BiotechnologyFORMA TherapeuticsGenentechLicensingOncologyPharmaceuticalRoche

Back to top